Percutaneous tibial nerve stimulation can help improve sexual function and bladder control in women with multiple sclerosis.
In this study, 65 women with multiple sclerosis who had bladder and sexual difficulties received a treatment called percutaneous tibial nerve stimulation (PTNS) for 12 weeks. This treatment helped many women feel better in areas like sexual desire, arousal, and even satisfaction. It also improved bladder control for more than half of the participants, which means fewer sudden urges to go to the bathroom. The women who did not receive PTNS did not show any improvements, highlighting how effective this treatment can be. It’s like finding a new tool in a toolbox that helps fix a problem that other tools couldn't solve.
Women with multiple sclerosis who experience sexual and bladder issues should pay attention to these findings because they offer hope for better quality of life. Caregivers can also benefit from understanding that there are new options available to help their loved ones feel more comfortable and satisfied. Healthcare providers can use this information to inform their patients about non-invasive treatments like PTNS that may significantly improve everyday life. Think of it as discovering a new path that makes a difficult journey a little easier. This study shows that there are effective, non-surgical ways to address these common challenges faced by MS patients.
It's important to remember that this study only included women, so we don't know if PTNS would have the same effects on men with MS. The study also had a small number of participants, which means more research is needed to confirm these results. Lastly, while the improvements were significant, individual experiences may vary, and not everyone may respond the same way to PTNS.
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More12/1/2026
Discover how the CEAM tool aids in understanding DNA changes in brain cells, offering hope for bette
Read More3/1/2026
Early OCT eye scans can often distinguish MOGAD from NMOSD optic neuritis, helping guide faster trea
Read More3/1/2026
Learn about the risks of enterovirus encephalitis for MS patients on ocrelizumab and how early recog
Read More3/1/2026
Learn how TREM2 helps brain immune cells switch to a repair mode, reduce inflammation, and may suppo
Read More3/1/2026
Discover how new research could help women with MS produce more IL-10, an important substance for co
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of clinical medicine often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.